Clinical value and molecular mechanism of AQGPs in different tumors

Med Oncol. 2022 Aug 16;39(11):174. doi: 10.1007/s12032-022-01766-0.

Abstract

Aquaglyceroporins (AQGPs), including AQP3, AQP7, AQP9, and AQP10, are transmembrane channels that allow small solutes across biological membranes, such as water, glycerol, H2O2, and so on. Increasing evidence suggests that they play critical roles in cancer. Overexpression or knockdown of AQGPs can promote or inhibit cancer cell proliferation, migration, invasion, apoptosis, epithelial-mesenchymal transition and metastasis, and the expression levels of AQGPs are closely linked to the prognosis of cancer patients. Here, we provide a comprehensive and detailed review to discuss the expression patterns of AQGPs in different cancers as well as the relationship between the expression patterns and prognosis. Then, we elaborate the relevance between AQGPs and malignant behaviors in cancer as well as the latent upstream regulators and downstream targets or signaling pathways of AQGPs. Finally, we summarize the potential clinical value in cancer treatment. This review will provide us with new ideas and thoughts for subsequent cancer therapy specifically targeting AQGPs.

Keywords: Aquaglyceroporin; Cancer; Expression pattern; Regulator; Signaling pathway.

Publication types

  • Review

MeSH terms

  • Aquaglyceroporins* / metabolism
  • Glycerol / metabolism
  • Humans
  • Hydrogen Peroxide
  • Neoplasms* / genetics

Substances

  • Aquaglyceroporins
  • Hydrogen Peroxide
  • Glycerol